Comparing overall survival of patients with metastatic uveal melanoma by sequence of Tebentafusp versus combination immune checkpoint inhibitors.

被引：0
|
作者：
Shikdar, Sufana
Day, Silas
Ikeguchi, Alexandra
Ying, Yuan
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[2] Univ Oklahoma, Med Ctr, Oklahoma City, OK USA
[3] Stephenson Canc Ctr, Oklahoma City, OK USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21505
引用
收藏
页数：1
相关论文
共 50 条
  • [11] The immune cell landscape of metastatic uveal melanoma correlates with overall survival
    Anna Tosi
    Rocco Cappellesso
    Angelo Paolo Dei Tos
    Valentina Rossi
    Camillo Aliberti
    Jacopo Pigozzo
    Alessio Fabozzi
    Marta Sbaraglia
    Stella Blandamura
    Paola Del Bianco
    Vanna Chiarion-Sileni
    Antonio Rosato
    Journal of Experimental & Clinical Cancer Research, 40
  • [12] UPDATED SURVIVAL OF PATIENTS WITH PREVIOUSLY TREATED METASTATIC UVEAL MELANOMA WHO RECEIVED TEBENTAFUSP
    Sacco, Joseph
    Carvajal, Richard
    Butler, Marcus
    Shoushtari, Alexander
    Hassel, Jessica
    Ikeguchi, Alexandra
    Hernandez-Aya, Leonel
    Nathan, Paul
    Hamid, Omid
    Piulats, Josep
    Rioth, Matthew
    Johnson, Douglas
    Luke, Jason
    Espinosa, Enrique
    Leyvraz, Serge
    Holland, Chris
    McCully, Michelle
    Abdullah, Shaad
    Sato, Takami
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A568 - A568
  • [13] Long-term survival outcomes with immune checkpoint inhibitors (ICI) in metastatic uveal melanoma (MUM).
    Lee, Cha Len
    Walsh, Naomi
    Keane, Fergus
    Lynch, Emer
    Reddan, Tadhg
    Craig, Helen
    O'Meara, Aileen
    Smith, Deirdre
    O'Neill, Valerie
    Horgan, Noel
    Kennedy, Susan
    Gullo, Giuseppe
    Crown, John
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [14] Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events
    Koch, Elias A. T.
    Petzold, Anne
    Dippel, Edgar
    Erdmann, Michael
    Gesierich, Anja
    Gutzmer, Ralf
    Hassel, Jessica C.
    Haferkamp, Sebastian
    Kaehler, Katharina C.
    Kreuzberg, Nicole
    Leiter, Ulrike
    Loquai, Carmen
    Meier, Friedegund
    Meissner, Markus
    Mohr, Peter
    Pfoehler, Claudia
    Rahimi, Farnaz
    Schell, Beatrice
    Terheyden, Patrick
    Thoms, Kai-Martin
    Ugurel, Selma
    Ulrich, Jens
    Utikal, Jochen
    Weichenthal, Michael
    Ziller, Fabian
    Berking, Carola
    Heppt, Markus V.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [15] Real-world impact of immune checkpoint inhibitors in metastatic uveal melanoma
    Bol, K. F.
    Ellebaek, E.
    Donia, M.
    Schmidt, H.
    Bastholt, L.
    Kiilgaard, J. F.
    Svane, I-M.
    ANNALS OF ONCOLOGY, 2019, 30 : 539 - 539
  • [16] Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
    Bol, Kalijn Fredrike
    Ellebaek, Eva
    Hoejberg, Lise
    Bagger, Mette Marie
    Larsen, Mathilde Skaarup
    Klausen, Tobias Wirenfeldt
    Kohler, Ulrich Heide
    Schmidt, Henrik
    Bastholt, Lars
    Kiilgaard, Jens Folke
    Donia, Marco
    Svane, Inge Marie
    CANCERS, 2019, 11 (10)
  • [17] Immune Prognostic Index as a predictor of survival in patients with metastatic melanoma treated with immune checkpoint inhibitors
    Stukalin, Igor
    Suo, Aleksi
    Vallerand, Isabelle A.
    Lewinson, Ryan
    Heng, Daniel Y. C.
    Bebb, D. Gwyn
    Morris, Don G.
    Cheng, Tina
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB100 - AB100
  • [18] Toxicity, response, and survival in older adults with metastatic melanoma treated with checkpoint inhibitors.
    De Glas, Nienke A.
    Bastiaannet, Esther
    Van den Bos, Frederiek
    Mooijaart, Simon
    Van der Veldt, Astrid Aplonia Maria
    Suijkerbuijk, Karijn
    Aarts, Maureen J. B.
    Van den Berkmortel, Franchette
    Blank, Christian U.
    Boers-Sonderen, Marye
    Van den Eertwegh, Alfonsus Johannes Maria
    de Groot, Jan Willem
    Hospers, Geke
    Haanen, John B. A. G.
    Piersma, Djura
    Van Rijn, Rozemarijn
    Ten Tije, A. J.
    Wouters, Michel W. J. M.
    Portielje, Johanna Elisabeth A.
    Kapiteijn, Ellen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [19] MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients
    Saint-Ghislain, Mathilde
    Derrien, Anne-Celine
    Geoffrois, Lionnel
    Gastaud, Lauris
    Lesimple, Thierry
    Negrier, Sylvie
    Penel, Nicolas
    Kurtz, Jean-Emmanuel
    Le Corre, Yannick
    Dutriaux, Caroline
    Gardrat, Sophie
    Barnhill, Raymond
    Matet, Alexandre
    Cassoux, Nathalie
    Houy, Alexandre
    Ramtohul, Toulsie
    Servois, Vincent
    Mariani, Pascale
    Piperno-Neumann, Sophie
    Stern, Marc-Henri
    Rodrigues, Manuel
    EUROPEAN JOURNAL OF CANCER, 2022, 173 : 105 - 112
  • [20] Development of a Metastatic Uveal Melanoma Prognostic Score (MUMPS) for Use in Patients Receiving Immune Checkpoint Inhibitors
    Kelly, Deirdre
    Rose, April A. N.
    Muniz, Thiago Pimentel
    Hogg, David
    Butler, Marcus O.
    Saibil, Samuel D.
    King, Ian
    Kamil, Zaid Saeed
    Ghazarian, Danny
    Ross, Kendra
    Iafolla, Marco
    Araujo, Daniel, V
    Waldron, John
    Laperriere, Normand
    Krema, Hatem
    Spreafico, Anna
    CANCERS, 2021, 13 (14)
12345